Skip to main content
OpenTrials

Clinical trial condition

Polycystic Kidney, Autosomal Dominant

Explore clinical trials studying Polycystic Kidney, Autosomal Dominant. Study availability and eligibility vary by location and protocol.

24 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Polycystic Kidney, Autosomal Dominant trial results

Recruiting

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

NCT07280585

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +11 more
Locations
  • Vorarlberger Krankenhaus-Betriebsgesellschaft Feldkirch, Austria
  • Medizinische Universitaet Innsbruck Innsbruck, Austria
  • Robert Bosch Gesellschaft für Medizinische Forschung mbH Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum Nürnberg Nuremberg, Bavaria, Germany
View all 30 locations
View Trial Details
Completed

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05521191

Conditions
ADPKD, Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, +13 more
Locations
  • Centricity Research Phoenix Multispecialty Mesa, Arizona, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • Yale Nephrology Outpatient Clinic New Haven, Connecticut, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

NCT01559363

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +11 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Denver Denver, Colorado, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions